DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Influx Healthtech Limited — Outcome of Board Meeting

NSE 1 hr ago·4 Nov 2026, 9:58 am

Influx Healthtech

Influx Healthtech Limited has informed stock exchanges that its board has approved the financial results for the period ending September 30, 2026. This update signals that the company has completed its internal review and reporting processes for the quarter, making the data official for public disclosure.

For investors, this announcement is a key milestone that confirms the availability of the company's latest performance metrics. It provides a concrete data point for assessing the company's current operational health and financial trajectory, allowing stakeholders to evaluate the business's progress against previous periods.

Investors should now focus on reviewing the detailed financial statements released alongside this announcement. Monitoring the company's revenue growth, profit margins, and cash flow will be essential to gauge the underlying business performance and determine the stock's future direction.